Indo Us Bio-Tech Ltd
BSE:541304
Indo Us Bio-Tech Ltd
BSE:541304
Price:
136.8
INR
0.11%
Market Closed
Market Cap:
₹2.7B
Income Statement
Earnings Waterfall
Indo Us Bio-Tech Ltd
Indo Us Bio-Tech Ltd
Income Statement
Indo Us Bio-Tech Ltd
Indo Us Bio-Tech Ltd
Currency: INR
| Mar-2020 | Sep-2020 | Mar-2021 | Sep-2021 | Mar-2022 | Sep-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Interest Expense |
8
|
0
|
11
|
0
|
11
|
0
|
11
|
0
|
0
|
0
|
14
|
0
|
0
|
0
|
14
|
0
|
0
|
0
|
|
| Revenue |
398
N/A
|
566
+42%
|
401
-29%
|
656
+64%
|
501
-24%
|
527
+5%
|
617
+17%
|
809
+31%
|
686
-15%
|
907
+32%
|
728
-20%
|
784
+8%
|
848
+8%
|
862
+2%
|
1 038
+20%
|
1 099
+6%
|
1 186
+8%
|
1 178
-1%
|
|
| Gross Profit | |||||||||||||||||||
| Cost of Revenue |
(318)
|
(446)
|
(253)
|
(445)
|
(362)
|
(377)
|
(451)
|
(594)
|
(486)
|
(640)
|
(494)
|
(531)
|
(577)
|
(580)
|
(727)
|
(767)
|
(859)
|
(863)
|
|
| Gross Profit |
79
N/A
|
120
+52%
|
148
+23%
|
211
+42%
|
139
-34%
|
150
+8%
|
166
+11%
|
214
+29%
|
199
-7%
|
266
+34%
|
235
-12%
|
253
+8%
|
271
+7%
|
283
+4%
|
312
+10%
|
332
+6%
|
326
-2%
|
315
-3%
|
|
| Operating Income | |||||||||||||||||||
| Operating Expenses |
(42)
|
(62)
|
(96)
|
(127)
|
(76)
|
(80)
|
(81)
|
(101)
|
(101)
|
(128)
|
(135)
|
(146)
|
(137)
|
(136)
|
(133)
|
(135)
|
(140)
|
(144)
|
|
| Selling, General & Administrative |
(6)
|
(9)
|
(5)
|
(8)
|
(51)
|
(11)
|
(56)
|
(18)
|
(15)
|
(18)
|
(72)
|
(11)
|
(10)
|
(10)
|
(63)
|
(11)
|
(12)
|
(13)
|
|
| Research & Development |
(12)
|
0
|
(21)
|
0
|
(20)
|
0
|
(16)
|
0
|
0
|
0
|
(55)
|
0
|
0
|
0
|
(60)
|
0
|
0
|
0
|
|
| Depreciation & Amortization |
(2)
|
(3)
|
(3)
|
(4)
|
(4)
|
(6)
|
(8)
|
(10)
|
(9)
|
(11)
|
(8)
|
(8)
|
(8)
|
(7)
|
(11)
|
(11)
|
(11)
|
(12)
|
|
| Other Operating Expenses |
(22)
|
(50)
|
(67)
|
(115)
|
(0)
|
(63)
|
0
|
(72)
|
(77)
|
(98)
|
0
|
(127)
|
(121)
|
(120)
|
0
|
(113)
|
(116)
|
(118)
|
|
| Operating Income |
37
N/A
|
58
+55%
|
53
-10%
|
84
+60%
|
63
-25%
|
70
+12%
|
86
+22%
|
113
+33%
|
98
-13%
|
139
+41%
|
100
-28%
|
107
+7%
|
132
+24%
|
146
+10%
|
178
+23%
|
196
+10%
|
186
-5%
|
172
-8%
|
|
| Pre-Tax Income | |||||||||||||||||||
| Interest Income Expense |
(8)
|
(14)
|
(11)
|
(18)
|
(11)
|
(11)
|
(12)
|
(16)
|
(15)
|
(18)
|
(15)
|
(15)
|
(16)
|
(16)
|
(15)
|
(16)
|
(15)
|
(19)
|
|
| Gain/Loss on Disposition of Assets |
(0)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
(1)
|
0
|
(0)
|
1
|
1
|
2
|
0
|
0
|
1
|
1
|
3
|
3
|
3
|
3
|
2
|
2
|
2
|
2
|
|
| Pre-Tax Income |
29
N/A
|
44
+54%
|
41
-6%
|
67
+63%
|
53
-21%
|
61
+15%
|
74
+21%
|
98
+33%
|
84
-14%
|
122
+45%
|
88
-28%
|
96
+9%
|
120
+25%
|
132
+11%
|
165
+25%
|
181
+10%
|
173
-5%
|
154
-11%
|
|
| Net Income | |||||||||||||||||||
| Tax Provision |
(3)
|
(4)
|
10
|
8
|
(2)
|
(4)
|
(1)
|
(2)
|
(2)
|
(3)
|
(6)
|
(5)
|
(3)
|
(2)
|
(3)
|
(4)
|
(4)
|
(6)
|
|
| Income from Continuing Operations |
25
|
40
|
51
|
76
|
51
|
57
|
72
|
96
|
82
|
119
|
83
|
91
|
118
|
132
|
163
|
178
|
169
|
148
|
|
| Net Income (Common) |
25
N/A
|
40
+58%
|
51
+27%
|
76
+48%
|
51
-33%
|
57
+13%
|
72
+27%
|
96
+33%
|
82
-15%
|
119
+45%
|
83
-30%
|
91
+10%
|
118
+30%
|
132
+12%
|
163
+23%
|
178
+10%
|
169
-5%
|
148
-12%
|
|
| EPS (Diluted) |
1.74
N/A
|
5.51
+217%
|
3.5
-36%
|
10.38
+197%
|
4.14
-60%
|
3.09
-25%
|
3.75
+21%
|
4.8
+28%
|
4.07
-15%
|
5.91
+45%
|
4.11
-30%
|
4.53
+10%
|
5.9
+30%
|
6.57
+11%
|
8.12
+24%
|
8.91
+10%
|
8.41
-6%
|
7.37
-12%
|
|
Switch to:
Switch to:
See Also
Discover More
